Closure of a large upper muscular ventricular septal defect in a 2.3 kg baby using a duct occluder

  • Mirza Mohd Kamran Assistant professor, Department of Pediatric Cardiology, PCE CS unit, JNMCH, AMU, Aligarh, India
  • Shaad Abqari Associate Professor, Department of Pediatrics, JNMCH, AMU, Aligarh, Uttar Pradesh, India
  • Azam Haseen Professor and Chairman, Department of CTVS, JNMCH, AMU, Aligarh, Uttar Pradesh, India
  • Mayank Yadav Assistant Professor, Department of CTVS, JNMCH, AMU, Aligarh, Uttar Pradesh, India
Keywords: Failure to thrive, Large VSD, Severe PAH, Transcatheter closure

Abstract

Surgical closure of the ventricular septal defect is a time tested and well-accepted procedure to date especially in smaller babies with failure to thrive and severe pulmonary hypertension. Surgical closure is regarded as the gold standard treatment. However over the past 10 years percutaneous trans-catheter device closure has emerged as a safer alternative especially in the case of muscular VSD. Transcatheter closure of ventricular septal defects (VSD) has not yet received general acceptance. It is not well-established in the younger age group with a weight category of less than 5 kg. Occasionally, a hybrid procedure has been proposed. We believe that certain types of VSD can be closed safely by the transcatheter approach even if weight is less than 5 kg, especially if the trend of miniaturizing devices continues. This approach should be considered as a valid alternative to a surgical option. We are reporting such a VSD baby with a weight of 2.3 Kg at the age of 6 months, which was closed with a duct occluder

Downloads

Download data is not yet available.

References

Lillehei Cw, Cohen M, Warden He, Ziegler Nr, Varco Rl. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet. 1955 Oct;101(4):446-66.

Chungsomprasong P, Durongpisitkul K, Vijarnsorn C, Soongswang J, Lê TP. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil. Catheter Cardiovasc Interv. 2011 Dec 1;78(7):1032-40. doi: 10.1002/ccd.23084.

Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007 Oct;28(19):2361-8. doi: 10.1093/eurheartj/ehm314.

Yang J, Yang L, Wan Y, Zuo J, Zhang J, Chen W, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J. 2010 Sep;31(18):2238-45. doi: 10.1093/eurheartj/ehq240.

Moodie DS. Technology Insight: transcatheter closure of ventricular septal defects. Nat Clin Pract Cardiovasc Med. 2005 Nov;2(11):592-6. doi: 10.1038/ncpcardio0351.

El Said HG, Bratincsak A, Gordon BM, Moore JW. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up. Catheter Cardiovasc Interv. 2012 Nov 15;80(6):895-903. doi: 10.1002/ccd.23074.

Dilawar M, Numan M, El-Sisi A, Gendi SM, Ahmad Z. Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder. Pediatr Cardiol. 2008 Mar;29(2):366-70. doi: 10.1007/s00246-007-9092-0.

CITATION
DOI: 10.17511/ijpr.2021.i03.07
Published: 2021-06-30
How to Cite
Mirza Mohd Kamran, Shaad Abqari, Azam Haseen, & Mayank Yadav. (2021). Closure of a large upper muscular ventricular septal defect in a 2.3 kg baby using a duct occluder. Pediatric Review: International Journal of Pediatric Research, 8(3), 163-167. https://doi.org/10.17511/ijpr.2021.i03.07
Section
Case Report